A large body of evidence suggests that TGF-β and its downstream signaling pathways, such as the Smad, MAPK, and AKT pathways, play a central role in the IPF pathogenesis10–12. The gene discussed is AKT1; the disease is idiopathic pulmonary fibrosis.